A significant number of other substances, many of them traded legally in large quantities, have been identified as precursors to the illicit manufacture of synthetic drugs and psychotropic substances. To subject these substances to the same strict controls as those listed in Annex I would present an unnecessary obstacle to trade involving licences to operate and documentation of transactions. Therefore, a more flexible mechanism at Community level should be established whereby the competent authorities in the Member States are notified of such transactions.
Recital 13, Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February…
Judgment of the Court (Fifth Chamber) of 5 February 2015. Miguel M. and Others.Decision
These requests for a preliminary ruling concern the interpretation of Article 2(a) of Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors (OJ 2004 L 47, p. 1) and of Article 2(a) …
5 Feb 2015 · 62013CJ0627
Judgment of the Court (Fifth Chamber) of 12 February 2015. N.F. Gielen and Others.Decision
This request for a preliminary ruling concerns the interpretation of Article 2(a), (b), (d) and (f) of Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors (OJ 2004 L 47, p. 1) …
12 Feb 2015 · 62013CJ0369
Judgment of the Court (Seventh Chamber) of 2 February 2023. Criminal proceedings against TF.Decision
Next, recitals 3, 6 and 17 of Regulation No 273/2004 make reference to a system for monitoring the ‘trade’ in drug precursors and recitals 5 and 11 thereof state, respectively, the need ‘to detect possible cases of illicit diversion …
2 Feb 2023 · 62021CJ0806